Doxorubicin as an adjuvant following surgery and radiation therapy in patients with high-risk endometrial carcinoma, stage I and occult stage II: A Gynecologic Oncology Group study

C. Paul Morrow, Brian N. Bundy, Howard D. Homesley, William T. Creasman, Ned B. Hornback, Robert Kurman, J. Tate Thigpen

Research output: Contribution to journal › Article › peer-review